MINI FUTURE SHORT - IDORSIA | Market Closed - Swiss Exchange 08:50:00 07/05/2024 pm IST | ||
| 5.46 CHF | -0.36% |
|
| 1 month | +1.30% | ||
| 3 months | -3.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IDORSIA LTD
Latest news about IDORSIA LTD
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/24/07 | 5.46 | -0.36% | 0 |
Delayed Quote Swiss Exchange
Last update May 07, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | IDORSIA LTD |
| Issuer | 
BNP Paribas
|
| OCJABP | |
| ISIN | CH0517860224 |
| Date issued | 13/02/2020 |
| Strike | 29.26 CHF |
| Maturity | Unlimited |
| Parity | 5 : 1 |
| Emission price | 0.97 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 5.66 CHF |
|---|---|
| Lowest since issue | 0.61 CHF |
| Spread | 0.02 CHF |
| Spread % | 0.37% |
Company Profile
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
Sector
-
Consensus: Idorsia Ltd
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
2.108
CHF
Average target price
1.724
CHF
Spread / Average Target
-18.23%
- Stock Market
- Certificates
- OCJABP Certificat